Old Web
English
Sign In
Acemap
>
authorDetail
>
Yutaka Aritomi
Yutaka Aritomi
Takeda Pharmaceutical Company
Antidepressant
Placebo
Discontinuation
Anesthesia
Major depressive disorder
3
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder
2018
Psychiatry and Clinical Neurosciences
Akira Nishimura
Yutaka Aritomi
Kiyofumi Sasai
Tadayuki Kitagawa
Atul R. Mahableshwarkar
Show All
Source
Cite
Save
Citations (14)
Pharmacokinetics, Safety, and Tolerability of Vortioxetine Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Adults
2018
Clinical pharmacology in drug development
Kumi Matsuno
Koki Nakamura
Yutaka Aritomi
Akira Nishimura
Show All
Source
Cite
Save
Citations (9)
Characterization of APOE and TOMM40 allele frequencies in the Japanese population
2017
Alzheimer's & Dementia: Translational Research & Clinical Interventions
Akira Nishimura
Hidenori Nonomura
Shingo Tanaka
Michihiro Yoshida
Yuka Maruyama
Yutaka Aritomi
Ann M. Saunders
Daniel K. Burns
Michael W. Lutz
Grant Runyan
Eric Lai
Kumar Budur
Allen D. Roses
Show All
Source
Cite
Save
Citations (11)
1